All In Biotech

NDA 206023 · Airgas USA LLC

Oxygen, Usp

Oxygen · Inhalation

Last checked: Nov 20, 2026Latest source record: Sep 7, 2013 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

2013

Sep 7, 2013

Approved uses

1

Original approval plus efficacy supplements

Registered trials

2,260

376 Phase 3, 196 recruiting

FAERS reports

50,900

33,888 serious, 7,316 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Oct 16, 2026.

No structured label for this application in openFDA. Older and discontinued products often have none.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Sep 7, 2013 Original approval · Medical Gas
1 products under this application
  • OXYGEN, USP · OXYGEN N/A · GAS, INHALATION · Prescription

Clinical trials

Interventional ClinicalTrials.gov studies with "Oxygen" as an intervention, any sponsor and status, largest first.

All 2,260 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • dyspnoea10,168
  • cough5,446
  • headache5,135
  • diarrhoea4,547
  • fatigue4,295
  • nausea4,124
  • pneumonia4,002
  • dizziness3,637
  • oxygen saturation decreased3,200
  • death2,668
  • hypotension2,430
  • asthenia2,418

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
2004347
2005353
2006446
2007487
2008603
2009735
2010984
20111,098
20121,238
20131,420
20141,796
20152,038
20162,550
20172,251
20182,528
20192,119
20202,680
20212,012
20221,876
20233,527
20246,661
20257,564
20265,585

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 30,749 on PubMed

Sponsor: Airgas USA LLC

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.